On today’s Good Day Health Show - ON DEMAND…

Host Doug Stephan and Dr. Ken Kronhaus of Lake Cardiology (352-735-1400) cover a number of topics affecting our health. First up, Doug and Dr. Ken discuss the biggest news stories in the medical world, starting with a focus on Tramadol and the risks associated with the opioid painkiller, used to treat moderate to severe pain in adults.

Next up, the discussion shifts to Repatha, a prescription cholesterol medication, and the conflicting information coming out about cholesterol based on outdated research. Continuing on the drug discussions, the FDA has approved a new drug, Jascayd, used to treat adults with Idiopathic Pulmonary Fibrosis — a chronic progressive, and usually fatal, lung disease. While most may think of Botox as only a cosmetic injectable, it’s also a medication. New research has found Botox to demonstrate statistically significant improvement in reducing the disability from the movement disorder associated with upper limb essential tremor compared to placebo.

A continued focus on alcohol consumption and that even light alcohol consumption can still cause damage to the brain with risk levels of dementia rising with a link between alcohol consumption and negative cognitive outcome.

Over the years, there has been research on symptoms of long-Covid, specifically brain fog — the inability to think as well as you did in the past — with advanced imaging showing widespread increase in the density of AMPA-receptors in the brains of long-Covid patients who suffer from brain fog.

Rounding out the program, Doug and Dr. Ken address the government shut down and how it affects medical care. Currently, there isn’t a great effect on the local basis, but the FDA is not currently approving new drugs or more new research grants during the shut down. Lastly, what it means when you have a good night’s sleep and wake up feeling exhausted still, felling unrested.

Website: GoodDayHealthrShow.com
Social Media: @GoodDayNetworks